BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10928299)

  • 1. The kidney and the neurogenic control of blood pressure in renal disease.
    Campese VM
    J Nephrol; 2000; 13(3):221-4. PubMed ID: 10928299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure.
    Campese VM; Ye S; Truong RH; Gamburd M
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):202-8. PubMed ID: 11967814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenic factors and hypertension in chronic renal failure.
    Campese VM
    J Nephrol; 1997; 10(4):184-7. PubMed ID: 9377724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications.
    Campese VM
    Clin Exp Nephrol; 2003 Sep; 7(3):167-71. PubMed ID: 14586711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.
    Phillips JK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):415-8. PubMed ID: 15854151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure.
    Campese VM; Mozayeni P; Ye S; Gumbard M
    J Nephrol; 2002; 15(4):407-13. PubMed ID: 12243372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenic factors and hypertension in renal disease.
    Campese VM
    Kidney Int Suppl; 2000 Apr; 75():S2-6. PubMed ID: 10828754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure.
    Ye S; Mozayeni P; Gamburd M; Zhong H; Campese VM
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2786-96. PubMed ID: 11087233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kidney and hypertension].
    Menne J; Fliser D; Haller H
    Herz; 2006 Jun; 31(4):317-21. PubMed ID: 16810471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kidney and hypertension: over 70 years of research.
    Campese VM; Park J
    J Nephrol; 2006; 19(6):691-8. PubMed ID: 17173239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurogenic factors in renal hypertension.
    Campese VM; Krol E
    Curr Hypertens Rep; 2002 Jun; 4(3):256-60. PubMed ID: 12003710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR; Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure.
    Hering D; Zdrojewski Z; Król E; Kara T; Kucharska W; Somers VK; Rutkowski B; Narkiewicz K
    J Hypertens; 2007 Jan; 25(1):157-61. PubMed ID: 17143187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic factors in hypertension: therapeutic implications.
    Campese VM
    Ann Ital Med Int; 1994 Oct; 9 Suppl():39S-43S. PubMed ID: 7857755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation.
    Despas F; Detis N; Dumonteil N; Labrunee M; Bellon B; Franchitto N; Galinier M; Senard JM; Pathak A
    J Hypertens; 2009 Sep; 27(9):1849-54. PubMed ID: 19542895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney's role in hypertension.
    Lubanski MS; McCullough PA
    Minerva Cardioangiol; 2009 Dec; 57(6):743-59. PubMed ID: 19942846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympatho-renal interactions in the determination of arterial pressure: role in hypertension.
    Grisk O
    Exp Physiol; 2005 Mar; 90(2):183-7. PubMed ID: 15604108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD; Bakris GL
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.
    Majid DS; Kopkan L
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):946-52. PubMed ID: 17645645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.